The U.S. FDA approved cardiovascular drugs from 2011 to 2023: A medicinal chemistry perspective
Yunhan Jiang(Sichuan University), Tao Yang(Sichuan University), Zhiqiang Qiu(Penn State Milton S. Hershey Medical Center), Pingxian Liu(Sichuan University), Mengdi Cheng(Sichuan University), Meng Zhou(Sichuan University)
Cited by 10
Related Papers
Inhibition of thioredoxin reductase 1 sensitizes glucose-starved glioblastoma cells to disulfidptosis
|Cell Death and Differentiation|2024|35
Advancing Tumor-Targeted Chemo-Immunotherapy: Development of the CAR-M-derived Exosome-Drug Conjugate
|Journal of Medicinal Chemistry|2024|18
Forkhead box O proteins: steering the course of stem cell fate
|Cell Regeneration|2024|12